Moreno Monedero M J, Acevedo León D, Caballero Ramón S, Vidal Martínez J, Moral Baltuille A, Perales Tortosa G, Casas Terrón E, Gil Minguillón C
Servicios de Análisis Clínicos y Bioquímica Clínica, Hospital Dr. Peset, Valencia.
Rev Esp Anestesiol Reanim. 1990 May-Jun;37(3):164-7.
We report 4 patients who had apnea of variable duration after succinylcholine administration to facilitate orotracheal intubation during anesthesia. After ruling out other causes of apnea unrelated to succinylcholine, we genotyped the cholinesterase variants of these patients and their relatives measuring total plasmatic cholinesterase activity and using the inhibitors dibucaine and fluoride. We found the silent gene (Es1) both in homozygosis (2 cases) and heterozygosis, with the atypical gene (Ea11) (2 cases). The relevance of preoperative screening to prevent anesthetic accidents is emphasized.
我们报告了4例患者,在麻醉期间使用琥珀酰胆碱以促进经口气管插管后,出现了持续时间不一的呼吸暂停。在排除了与琥珀酰胆碱无关的其他呼吸暂停原因后,我们对这些患者及其亲属的胆碱酯酶变体进行了基因分型,测量了血浆总胆碱酯酶活性,并使用了抑制剂丁卡因和氟化物。我们发现纯合子(2例)和杂合子中均存在沉默基因(Es1),以及非典型基因(Ea11)(2例)。强调了术前筛查对预防麻醉意外的相关性。